Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ryr2tm2.1Wex mutation
(0 available);
any
Ryr2 mutation
(325 available)
Tg(Myh6-EGFP/AC3I)#Mean mutation
(0 available)
|
|
|
cardiovascular system
|
• that is slightly less than in Ryr2tm2.1Wex homozygotes
• incidence of tachycardia in isoproterenol-treated mice is the same as in Ryr2tm2.1Wex homozygotes
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
|
|
|
mortality/aging
|
• STZ-treated mice subjected to myocardial infarction exhibit resistance to increased mortality compared with similarly treated wild-type mice
|
cardiovascular system
|
• STZ-treated mice subjected to myocardial infarction (MI) exhibit improved intrinsic sinus node function compared with similarly treated wild-type mice
|
|
• streptozotocin (STZ)-treated mice subjected to myocardial infarction (MI) exhibit resistance to increased mortality with increased resting heart rate, reduced episodes of very low heart rate, improved activity-related heart rate increases, improved intrinsic sinus node function, reduced apoptosis in the sinoatrial node and reduced fibrosis compared with similarly treated wild-type mice
• however, STZ mice subjected to MI exhibit normal left ventricle contractile function and volume
|
homeostasis/metabolism
cellular
|
• in the sinoatrial node of STZ-treated mice subjected to myocardial infarction
|